Gallocin-derived Engineered Peptides Targeting EGFR and VEGFR in Colorectal Cancer: A Bioinformatic Approach.
Batoul KavyaniAli AfgarSajjad KavyaniMasoud RezaeiFatemeh SharifiRoya AhmadrajabiFereshteh SaffariPublished in: Current topics in medicinal chemistry (2024)
Designed peptides can be nominated as drugs for CRC treatment. However, different in-vitro and in-vivo assessments are required to approve this claim.